Table 3. Comparable outcomes of included skin cancer studies: teledermatology.

Study	Lesions assessed, n	Scan outcomes, % of number of lesions assessed	Follow-ups recommended, n (%)	Follow-up available, n	% of diagnoses of available follow-up scans
Mendonca et al 46	225	53.8% benign, 23.1% NMSC precursor, 16.4% dubious, 5.8% NMSC, 0.9% melanoma	n/a	n/a	n/a
Kirkdale et al 44	9980	88.7% no follow-up required: 57.4% normal, 22.4% SK, 6.1% potential sun damage, 1.7% other normal lesion, 1.1% normal with atypical characteristics	1118 (11.3)	757	44.3% normal, 26.0% sun damage, 11.0% BCC, 6.6% other, 6.2% melanoma, 3.0% SK, 2.5% atypical, 0.4% SCC
Kjome et al 45	25 836	92.1% no follow-up required: 88.3% normal, 2.4% benign skin damage, 1.4% other benign skin condition	2033 (7.9)	1793	51.0% normal, 2.5% sun damage, 23.0% other skin condition, 8.6% cancer or pre-cancer melanoma, 9.3% other skin cancer, 5.6% no outcome

BCC = basal cell carcinoma. n/a = not applicable. NMSC = non-melanoma skin cancer. SCC = squamous cell carcinoma. SK = seborrheic keratosis.